The US Court of Appeals for the Second Circuit states that direct purchasers of antidiuretic medicine have antitrust standing in patent infringement suit (DDAVP)

2nd Circuit finds DDAVP purchasers stated Walker Process and related claims and had antitrust standing* On 16 October 2009 the Court of Appeals for the Second Circuit held (In re: DDAVP Direct Purchaser Antitrust Litigation) that direct purchasers of desmopressin acetate tablets, sold under the name DDAVP, stated Walker Process and related antitrust claims and had antitrust standing to do so. The Court thus vacated a U.S. District Court (S.D.N.Y.)

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Stanford University - Stanford Law School

Quotation

Juha Vesala, The US Court of Appeals for the Second Circuit states that direct purchasers of antidiuretic medicine have antitrust standing in patent infringement suit (DDAVP), 16 October 2009, e-Competitions October 2009, Art. N° 58474

Visites 222

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues